Ardelle Ying

Ardelle Ying is a Senior Program Director at Genentech, bringing over 15 years of leadership in regulatory affairs. With extensive experience in global regulatory development, Ardelle has shaped and executed strategies for multiple products across various therapeutic areas, focusing on compliance and business alignment in the U.S. and China. Previously, Ardelle held multiple roles, including Senior Director and Associate Program Director, managing regulatory activities for significant products like Actemra® and Perjeta®. Ardelle earned a Doctor of Philosophy (Ph.D.) in Molecular Medicine from Boston University School of Medicine and a Doctor of Medicine (M.D.) from Beijing University Health Science Center.